Drugs for Cervical Cancer

Table. Drugs Prescribed for Cervical Cancer

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Avastin (bevacizumab) Injection
Drug company
• Genentech
Indication
• Treatment of recurrent, persistent, or metastatic cervical cancer, in combination with paclitaxel and cisplatin or paclitaxel and topotecan
Patient support services
• Genentech Oncology Copay Assistance Program
  855-692-6729
  
  Genentech Patient Foundation
  888-941-3331

Drug name (generic name)
• Hycamtin (topotecan) Injection
Drug company
• Novartis
Indication
• Treatment of stage IVB, recurrent or persistent carcinoma of the cervix, in combination with cisplatin
Patient support services
• Novartis Patient Assistance Foundation
  800-277-2254

Drug name (generic name)
• Keytruda (pembrolizumab)
Drug company
• Merck
Indication
• Treatment of recurrent or metastatic cervical cancer progressing during or after chemotherapy in patients whose tumors express PD-L1, as determined by an FDA-approved test
  
  Treatment, in combination with chemotherapy and with or without Avastin, in patients with persistent, recurrent, or metastatic cervical cancer whose tumor expresses PD-L1, as determined by an FDA-approved test
Patient support services
• Merck Co-pay Assistance Program
  855-257-3932
  
  Merck Patient Assistance Program
  855-257-3932

Drug name (generic name)
• Mvasi (bevacizumab-awwb)
Drug company
• Amgen
Indication
• Treatment of persistent, recurrent, or metastatic cervical cancer, in combination with chemotherapy
Patient support services
• Amgen FIRST STEP Co-Pay Program
  866-264-2778
  
  Amgen Safety Net Foundation
  866-264-2778

Drug name (generic name)
• Tivdak (tisotumab vedotin-tftv) Injection
Drug company
• Seagen
Indication
• Treatment of adults with recurrent or metastatic cervical cancer whose disease progressed during or after chemotherapy
Patient support services
• Commercial Out-Of-Pocket Assistance Program
  855-473-2873
  
  Patient Assistance Program
  855-473-2873

Drug name (generic name)
• Zirabev (bevacizumab-bvzr)
Drug company
• Pfizer
Indication
• Treatment, in combination with paclitaxel and cisplatin or paclitaxel and topotecan, of persistent, recurrent, or metastatic cervical cancer
Patient support services
• Pfizer Oncology Together Co-Pay Savings Program
  877-744-5675
  
  Pfizer Patient Assistance Program
  877-744-5675